Merck reported revenue for the fourth quarter was $16.4 billion, an increase of 5% over the fourth quarter of 2024. For the ...

Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open. Wall Street expects earnings of $2.01 per ...

Merck quashed fourth-quarter expectations Tuesday, but the Dow Jones health giant issued lackluster expectations for 2026.

Merck Group, the German pharmaceutical company, saw its Frankfurt-listed shares fall 10% on Tuesday morning after the company said it had decided to call off a Phase III trial of its cancer drug ...

Merck & Co., Inc. (NYSE:MRK) is one of the best long term low volatility stocks to invest in. Merck & Co., Inc. (NYSE:MRK) announced on January 27 that its Board of Directors declared a quarterly ...

For full-year 2025, Merck reported worldwide sales of $65B, up 1% Y/Y, or 2% excluding FX, while adjusted EPS totaled $8.98.

Merck KGaA (XTRA:MRK) has appointed Benjamin Hein as chief executive of its Electronics business sector. Hein will also join ...

Merck (NYSE:MRK) has ended acquisition talks with oncology-focused Revolution Medicines. The discussions centered on a ...

Merck has appointed Benjamin Hein as a new member of its executive board and CEO of the company’s Electronics Business. The company announced on ...

German science and technology group Merck said Friday it has appointed Benjamin Hein, 38, as chief executive of its ...